A welcome move by Glenmark_Price cuts for Anti-cancer drugs

-
In a welcome move by India's leading pharmaceutical drug producer Glenmark Pharmaceuticals, the company has reduced the price for Erleva (erlotinib), Geftib (gefitinib) and Pexotra (pemetrexed) by about 55-70%. These drugs are used for the treatment of lung cancer.
 
 
The new prices of cancer drugs are as follows:
  • Erleva (150 mg, 30 tablets) is Rs 9,700 (drop of 67.66% ),
  • Geftib tablets 250 mg (1 box of 3 strips of 10 tablets each) is Rs 3,999 (drop of 63.63% );
  • Pexotra injection 100 mg (1 vial) is Rs 2,000 (fall of 56% ) and
  • Pexotra injection 500 mg (1 vial) is Rs 8,000 (fall of 60.87%).
 
Sujesh Vasudevan, executive VP, Glenmark, told DNA that more price reductions in different segments of the company's cancer drug portfolio are on the cards.
 
 

Comments

Post a Comment

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

-
The China-India joint summit held recently discussed bilateral trade to improve Indo- China pharma industry and address issues like long product registration time and high fees for product registration in China’s drug regulatory system, among other issues.  Besides this, other relevant key issues related to transparency in public procurement system in China and clinical trial related approvals were also deliberated at the summit organised under the aegis of Indian Pharmaceutical Association (IPA), Shengjie and SaSPinjara, China between May 16 and May 17, 2019 at Pullman Shanghai South, China. The summit was focused on enhancing export business for both the nations across the globe. Senior health ministry official from Government of Gujarat Punamchand Parmar was invited as the Chief Guest of the summit and Gujarat Food and Drugs Control Administration (FDCA) Commissioner Dr Hemant Koshia was invited as Guest of Honour.  Among other dignitaries, Dr. Anil Kumar Rai, Consulate General of
Read more

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’

-
Image
“IDEA TO MARKET” is an idea hunt to commercialize the herbal inventions. It is a platform for researchers to use their innovative ideas in the area of herbal research and get the products commercialized in collaboration with corporate partners.  Hurry up and register for the webinar to know more about this program. The webinar is organized by Bombay College of Pharmacy and Pharma Literati.  Registration Link for webinar on OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH: https://docs.google.com/forms/d/e/1FAIpQLSfUhe1LtCOjG50SilFw_iECnzBXu4CW0nK2wIvd8QVVvpDOzQ/viewform
Read more